A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancer Article

Hochster, H, Speyer, JL, Mandeli, JP et al. (1999). A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancer . GYNECOLOGIC ONCOLOGY, 72(3), 292-297. 10.1006/gyno.1998.5261

Open Access

cited authors

  • Hochster, H; Speyer, JL; Mandeli, JP; Runowicz, C; Wadler, S; Berk, G; Wallach, R; Holland, JF

sustainable development goals

publication date

  • March 1, 1999

published in

keywords

  • CYCLOPHOSPHAMIDE
  • Life Sciences & Biomedicine
  • Obstetrics & Gynecology
  • Oncology
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • ACADEMIC PRESS INC

start page

  • 292

end page

  • 297

volume

  • 72

issue

  • 3